These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 31441020)

  • 21. Circular RNA circ-CCAC1 Facilitates Adrenocortical Carcinoma Cell Proliferation, Migration, and Invasion through Regulating the miR-514a-5p/C22orf46 Axis.
    Li W; Liu R; Wei D; Zhang W; Zhang H; Huang W; Hao L
    Biomed Res Int; 2020; 2020():3501451. PubMed ID: 33195693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients.
    Bai T; Yokobori T; Altan B; Ide M; Mochiki E; Yanai M; Kimura A; Kogure N; Yanoma T; Suzuki M; Bao P; Kaira K; Asao T; Katayama A; Handa T; Gombodorj N; Nishiyama M; Oyama T; Ogata K; Kuwano H
    Br J Cancer; 2017 Apr; 116(9):1177-1185. PubMed ID: 28334732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adrenocortical Carcinoma Steroid Profiles:
    Muzzi JCD; Magno JM; Cardoso MA; de Moura J; Castro MAA; Figueiredo BC
    Front Endocrinol (Lausanne); 2021; 12():672319. PubMed ID: 34194394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of stathmin 1 is a poor prognostic biomarker in non-small cell lung cancer.
    Nie W; Xu MD; Gan L; Huang H; Xiu Q; Li B
    Lab Invest; 2015 Jan; 95(1):56-64. PubMed ID: 25384122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of FGF Receptors and Their Pathways in Adrenocortical Tumors and Possible Therapeutic Implications.
    Sbiera I; Kircher S; Altieri B; Lenz K; Hantel C; Fassnacht M; Sbiera S; Kroiss M
    Front Endocrinol (Lausanne); 2021; 12():795116. PubMed ID: 34956100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.
    Altieri B; Sbiera S; Della Casa S; Weigand I; Wild V; Steinhauer S; Fadda G; Kocot A; Bekteshi M; Mambretti EM; Rosenwald A; Pontecorvi A; Fassnacht M; Ronchi CL
    Oncotarget; 2017 Feb; 8(6):9323-9338. PubMed ID: 28030838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma.
    Shen C; Liu J; Yang X; Jiao W; Wang Y
    Front Endocrinol (Lausanne); 2021; 12():568397. PubMed ID: 33692753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma.
    Watanabe A; Suzuki H; Yokobori T; Tsukagoshi M; Altan B; Kubo N; Suzuki S; Araki K; Wada S; Kashiwabara K; Hosouchi Y; Kuwano H
    Cancer Sci; 2014 Jun; 105(6):690-6. PubMed ID: 24708177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiplatform computational analysis of mast cells in adrenocortical carcinoma tumor microenvironment.
    Baechle JJ; Hanna DN; Sekhar KR; Rathmell JC; Rathmell WK; Baregamian N
    Surgery; 2022 Jan; 171(1):111-118. PubMed ID: 34261605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients.
    Liang J; Liu Z; Wei X; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Lu Y; Zhu Y
    BMC Cancer; 2019 Nov; 19(1):1165. PubMed ID: 31783819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Over expression of DNA damage and cell cycle dependent proteins are associated with poor survival in patients with adrenocortical carcinoma.
    Subramanian C; Cohen MS
    Surgery; 2019 Jan; 165(1):202-210. PubMed ID: 30413320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stathmin1 overexpression in hypopharyngeal squamous cell carcinoma: A new promoter in FaDu cell proliferation and migration.
    Chen Y; Zhang Q; Ding C; Zhang X; Qiu X; Zhang Z
    Int J Oncol; 2017 Jan; 50(1):31-40. PubMed ID: 27878293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The underlying molecular mechanism and drugs for treatment in adrenal cortical carcinoma.
    Ma C; Xiong J; Su H; Li H
    Int J Med Sci; 2021; 18(13):3026-3038. PubMed ID: 34220331
    [No Abstract]   [Full Text] [Related]  

  • 34. IL-13Rα2 gene expression is a biomarker of adverse outcome in patients with adrenocortical carcinoma.
    Kumar A; Bellayr IH; Singh HS; Puri RK
    PLoS One; 2021; 16(2):e0246632. PubMed ID: 33591997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.
    Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishing a human adrenocortical carcinoma (ACC)-specific gene mutation signature.
    Rahane CS; Kutzner A; Heese K
    Cancer Genet; 2019 Jan; 230():1-12. PubMed ID: 30477734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma.
    Liang R; Weigand I; Lippert J; Kircher S; Altieri B; Steinhauer S; Hantel C; Rost S; Rosenwald A; Kroiss M; Fassnacht M; Sbiera S; Ronchi CL
    Front Endocrinol (Lausanne); 2020; 11():219. PubMed ID: 32373071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma.
    Scatolini M; Grisanti S; Tomaiuolo P; Grosso E; Basile V; Cosentini D; Puglisi S; Laganà M; Perotti P; Saba L; Rossini E; Palermo F; Sigala S; Volante M; Berruti A; Terzolo M
    Eur J Cancer; 2024 Jul; 205():114088. PubMed ID: 38714106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma.
    Liang W; Sun F
    Front Endocrinol (Lausanne); 2021; 12():538364. PubMed ID: 33776902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survivin in adrenocortical tumors - pathophysiological implications and therapeutic potential.
    Sbiera S; Kroiss M; Thamm T; Beyer M; Majidi F; Kuehner D; Wobser M; Becker JC; Adam P; Ronchi C; Allolio B; Fassnacht M
    Horm Metab Res; 2013 Feb; 45(2):137-46. PubMed ID: 23143666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.